SCHEMBL18459255

SCHEMBL18459255

CCc1ccc([C@H]2[C@@H](C)[C@H]2N)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
BRCA1 P38398 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TAAR1 Q96RJ0 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.38
CA2 P00918 1/20 0.38
TP53 P04637 2/20 0.37
PLAU P00749 1/20 0.36
CYP2A6 P11509 1/20 0.35
LPL P06858 1/20 0.35
LIPG Q9Y5X9 1/20 0.35
IDO1 P14902 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18459256 1.00 ALDH1A1 (0.43) ALDH1A1KDM4EMEN1MAPTHPGD
Hydrochloric Acid SCHEMBL15200649 0.71 KDM1A (0.39) ALDH1A1KMT2ATAAR1CYP2A6
Hydrochloric Acid SCHEMBL15200728 0.71 KDM1A (0.39) ALDH1A1KMT2ATAAR1CYP2A6
SCHEMBL18459573 0.70 HPGD (0.41) ALDH1A1KDM4EMEN1MAPTHPGD
SCHEMBL15149972 0.70 KDM1A (0.54) HSD17B10TAAR1CYP2A6
SCHEMBL18459317 0.70 HPGD (0.41) ALDH1A1KDM4EMEN1MAPTHPGD
Methylamine SCHEMBL27540106 0.69 TAAR1 (0.63) ALDH1A1TAAR1SMN1; SMN2CA2TP53
SCHEMBL36295 0.69 TP53 (0.67) ALDH1A1TAAR1SMN1; SMN2CA2TP53
SCHEMBL4409 0.68
Hydrazine SCHEMBL28200204 0.67 TAAR1 (0.60) ALDH1A1TAAR1SMN1; SMN2CA2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170029366-A1 INHIBITORS OF HISTONE LYSINE SPECIFIC DEMETHYLASE (LSD1) AND HISTONE DEACETYLASES (HDACS) THE JOHNS HOPKINS UNIVERSITY (US) 2017-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170029366-A1 INHIBITORS OF HISTONE LYSINE SPECIFIC DEMETHYLASE (LSD1) AND HISTONE DEACETYLASES (HDACS) KDM1B, KDM2A, EHMT2 ALDH1A1 1450/4885KDM4E 21/4885MEN1 4354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.